These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 3453151

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prevalence of antibody to hepatitis D virus among HBsAg-positive drug-dependent patients in Jeddah, Saudi Arabia.
    Njoh J, Zimmo S.
    East Afr Med J; 1998 Jun; 75(6):327-8. PubMed ID: 9803612
    [Abstract] [Full Text] [Related]

  • 23. Lack of evidence of hepatitis D (delta) infection in Newfoundland and Labrador.
    Ratnam S, Head CB, Butler RW.
    CMAJ; 1986 Apr 15; 134(8):905-7. PubMed ID: 3955485
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN, Chen TM, Lee CM, Wang JH, Tung HD, Wu JC.
    J Med Virol; 2003 May 15; 70(1):74-80. PubMed ID: 12629646
    [Abstract] [Full Text] [Related]

  • 28. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK, Ayaz C, Hosoglu S, Geyik MF, Ulug M.
    Saudi Med J; 2006 May 15; 27(5):617-20. PubMed ID: 16680248
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Anti-HBc titers and anti-HBc immunoglobulin (M/G) classes in acute, chronic and resolved hepatitis B.
    Niermeijer P, Gips CH, Huizenga JR, Houthoff HJ, Snijder JA.
    Hepatogastroenterology; 1980 Aug 15; 27(4):271-6. PubMed ID: 7203363
    [Abstract] [Full Text] [Related]

  • 31. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.
    Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T, Piccinino F.
    Hepatology; 2000 Nov 15; 32(5):1106-10. PubMed ID: 11050062
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H.
    J Med Virol; 2005 Dec 15; 77(4):491-9. PubMed ID: 16254981
    [Abstract] [Full Text] [Related]

  • 38. The role of the hepatitis delta virus in acute hepatitis and in chronic liver disease in Greece.
    Hadziyannis SJ, Papaioannou C, Alexopoulou A.
    Prog Clin Biol Res; 1991 Dec 15; 364():51-62. PubMed ID: 2020721
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.